Literature DB >> 18510608

Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.

Praveen Sharma1, Barjesh C Sharma, Vinod Puri, Shiv K Sarin.   

Abstract

BACKGROUND AND AIMS: Minimal hepatic encephalopathy (MHE) is associated with poor quality of life and increased work disability in cirrhotic patients. Its prevalence in extrahepatic portal vein obstruction (EHPVO) is not known. We studied the prevalence of MHE in EHPVO patients and utility of critical flicker frequency (CFF) for diagnosing MHE. PATIENTS AND METHODS: Thirty-four EHPVO patients with a history of variceal bleed (age 23.2 +/- 11.2 yr, M:F 22:12) diagnosed by either Doppler US or MR angiography, which demonstrated portal vein obstruction and/or portal vein cavernoma, were evaluated by psychometry (number connection tests A, B or figure connection tests A, B) and P300 auditory event-related potential (P300ERP). CFF was also evaluated. MHE was diagnosed by abnormal psychometry (>2 standard deviation [SD]) and/or P300ERP (>2.5 SD).
RESULTS: Prevalence of MHE (N = 12) was 35.3%. Of 34 patients, P300ERP was abnormal (380.0 +/- 28.9 msec) in 11 (32%), psychometry in 9 (26.4%), both P300ERP and psychometry in 8 (23.5%), and CFF <38 Hz in 7 (21%) patients. Six (67%) patients with abnormal psychometry and 7 (64%) with abnormal P300ERP had CFF below 38 Hz. CFF had sensitivity (75%), specificity (96%), positive predictive value (86%), negative predictive value (93%), and diagnosis accuracy of 91% when compared to patients with both abnormal psychometry and P300ERP. The venous ammonia level was higher in patients with MHE (83.1 +/- 29.7 vs 44.7 +/- 16.1 micromol/L, P < 0.001) compared to patients without MHE. Spontaneous shunts were present in 67% of patients with MHE compared to 14% of non-MHE patients. MHE was more common in patients with spontaneous shunts (72.7%vs 17.4%, P= 0.001) than without spontaneous shunts.
CONCLUSIONS: Prevalence of MHE in EHPVO patients is 35.3%, and CFF alone can reliably diagnose 88% of MHE patients with both abnormal psychometry and P300ERP. However, in view of the relatively low number of patients with MHE, the usefulness of CFF in this setting awaits confirmatory studies.

Entities:  

Mesh:

Year:  2008        PMID: 18510608     DOI: 10.1111/j.1572-0241.2008.01830.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  Current Stance of Magnetic Resonance Imaging in the Diagnosis and Monitoring of Hepatic Encephalopathy.

Authors:  Cristian Scheau; Roxana Dinu; Eugen Tarta-Arsene; Andreea Elena Scheau; Ioana Anca Badarau; Ioana Gabriela Lupescu
Journal:  Maedica (Buchar)       Date:  2015-09

Review 2.  The diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Tianzuo Zhan; Wolfgang Stremmel
Journal:  Dtsch Arztebl Int       Date:  2012-03-09       Impact factor: 5.594

3.  A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.

Authors:  Hanaa Mostafa El-Karaksy; Omneya Afifi; Azza Bakry; Ann Abdel Kader; Noha Saber
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

Review 4.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

5.  Brain MR imaging and 1H-MR spectroscopy changes in patients with extrahepatic portal vein obstruction from early childhood to adulthood.

Authors:  S K Yadav; S Saksena; Anshu Srivastava; Arti Srivastava; V A Saraswat; M A Thomas; R K S Rathore; Rakesh K Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-11       Impact factor: 3.825

Review 6.  Minimal hepatic encephalopathy.

Authors:  Radha K Dhiman; Yogesh K Chawla
Journal:  Indian J Gastroenterol       Date:  2009 Jan-Feb

7.  Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.

Authors:  Praveen Sharma; Barjesh Chander Sharma
Journal:  Saudi J Gastroenterol       Date:  2012 May-Jun       Impact factor: 2.485

8.  What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides?

Authors:  Hanan A Alfawaz; Abdulrahman A Aljumah
Journal:  Saudi J Gastroenterol       Date:  2012 May-Jun       Impact factor: 2.485

9.  Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy.

Authors:  F J Torlot; M J W McPhail; S D Taylor-Robinson
Journal:  Aliment Pharmacol Ther       Date:  2013-01-07       Impact factor: 8.171

10.  Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.

Authors:  Kapil Sharma; Sanjay Pant; Sriprakash Misra; Manisha Dwivedi; Alok Misra; Sushil Narang; Reshu Tewari; Ajeet S Bhadoria
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.